aod9604 recommended dosage PDF) Peptides: AOD-9604 & BPC-157 AOD 9604 Peptide Guide: Dosing,

Heffernan 2001b This metabolic selectivity has a dosage implication: once the beta-3 receptors in adipose tissue are adequately occupied, additional peptide does not proportionally increase the lipolytic signal

Side effect diary noting any GI symptoms, energy changes, sleep quality, or injection site reactions

Help us make a difference

Rare side effects Increased appetite: Paradoxical for a fat loss peptide, but some users report increased hunger

Tirzepatide activates the following gut hormone receptors: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) This process reduces hunger while delaying food from getting to the small intestine